👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

India vaccinates 3.8 million teens in new COVID-19 inoculation push

Published 01/03/2022, 01:15 AM
Updated 01/03/2022, 08:27 AM
© Reuters. A girl receives a dose of the COVAXIN coronavirus disease (COVID-19) vaccine manufactured by Bharat Biotech, during a vaccination drive for children aged 15-18 in New Delhi, India, January 3, 2022. REUTERS/Adnan Abidi
AZN
-

MUMBAI (Reuters) -India vaccinated more than 3.8 million teens aged between 15 and 18 years on Monday, as the country expanded an inoculation effort to protect its large adolescent population ahead of a looming wave of coronavirus infections.

The teenagers, many wearing their uniforms, queued at schools and health centres across the country as health workers injected them with Bharat Biotech's Covaxin - the only COVID-19 vaccine so far approved by India for those below 18 years.

The drive has come amid a sharp rise in cases in India, with the federal health ministry on Monday reporting 33,750 new infections and 123 deaths. The total number of cases of the fast-spreading Omicron variant detected in India was 1,700.

Data from the health ministry's CoWIN portal showed that 3.85 million doses of vaccines had been administered to those aged between 15 and 17 years on Monday.

Kishan Bhuyan, 17, queued with friends in the eastern city of Bhubaneswar after registering online for the COVID-19 jab.

"I was waiting for this (vaccination) for so long," Bhuyan, a high school student, said after receiving his vaccine. "I am now protected."

Several countries including the United States https://www.reuters.com/world/us/covid-19-hospitalization-surge-among-us-children-spurs-new-omicron-concerns-2021-12-30, Britain and South Korea https://www.reuters.com/business/cop/skorean-teens-drive-up-covid-19-cases-ahead-full-school-reopening-2021-11-03 have seen infections among children fuelling a rise in cases in recent weeks and have encouraged parents to get their children vaccinated.

India has more than 120 million people aged between 15 and 19 years, according to the country's 2011 Census, and the largest population of adolescents in the world, as per UNICEF estimates.

© Reuters. A girl receives a dose of the COVAXIN coronavirus disease (COVID-19) vaccine manufactured by Bharat Biotech, during a vaccination drive for children aged 15-18 in New Delhi, India, January 3, 2022. REUTERS/Adnan Abidi

Some Indian states have set ambitious vaccination targets. Authorities in Gujarat, which is Prime Minister Narendra Modi's home state, are hoping to give a first dose to 3.6 million teens this week.

"We have the capacity and we have the vaccines to cover most of the children. We appeal to parents to cooperate and ensure the children are vaccinated at the earliest," said Jai Prakash Shivahare, Gujarat's health commissioner.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.